Clinical trial

Topical Tacrolimus for Breast Cancer-related Lymphedema

NCT06306274

StatusENROLLING_BY_INVITATION

Study typeINTERVENTIONAL

Start date2024-09-09

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2024-09-09Date precision: day

Registry last updated2024-12-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lymphedemaunresolved

Interventions

TacrolimusDRUG · verified · RxNorm: tacrolimus

PlaceboDRUG

Sponsors & collaborators

Odense University Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06306274 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.